Biogenetic Drugs Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.94 Cr
- Company Age 21 Year, 10 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 31.43 Cr
- Satisfied Charges ₹ 26.71 Cr
About Biogenetic Drugs
Biogenetic Drugs Private Limited (BDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 January 2004 and has a history of 21 years. Its registered office is in Jaipur, Rajasthan.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.94 Cr.
The company currently has active open charges totaling ₹31.43 Cr. The company has closed loans amounting to ₹26.71 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mukut Goyal and Vibhor Goyal serve as directors at the Company.
Company Details
-
LocationJaipur, Rajasthan
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232RJ2004PTC018909
-
Company No.
018909
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Jan 2004
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Biogenetic Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vibhor Goyal
|
Director | 21-Jan-2012 | Current |
|
Mukut Goyal
|
Director | 23-Jan-2004 | Current |
Financial Performance of Biogenetic Drugs.
Biogenetic Drugs Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biogenetic Drugs?
In 2024, Biogenetic Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Smilax Psyllium Impex LlpMukut Goyal and Vibhor Goyal are mutual person
-
Cynamid Pharmachem Llp
Mukut Goyal and Vibhor Goyal are mutual person
-
Shiana Impex Llp
Mukut Goyal is a mutual person
-
Duramed Healthcare (India) Llp
Mukut Goyal is a mutual person
-
Smilax Pharmaceuticals Private Limited
Mukut Goyal is a mutual person
-
Wright Care Drugs Private Limited
Mukut Goyal is a mutual person
Charges (Loans)
₹31.43 Cr
₹26.71 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 31.43 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2023 | State Bank Of India | ₹7.25 Cr | Open |
| 30 Oct 2017 | State Bank Of India | ₹24.18 Cr | Open |
| 14 Mar 2017 | Sidbi | ₹3.10 Cr | Satisfied |
| 11 Nov 2011 | Small Industries Development Bank Of India | ₹3.50 M | Satisfied |
| 21 Apr 2011 | Union Bank Of India | ₹1.10 Cr | Satisfied |
How Many Employees Work at Biogenetic Drugs?
Unlock and access historical data on people associated with Biogenetic Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biogenetic Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogenetic Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
